Today, the CFO of Endologix Inc (NASDAQ: ELGX), Mahboob Vaseem, bought shares of ELGX for $72.9K.
This recent transaction increases Mahboob Vaseem’s holding in the company by 25.68% to a total of $372.9K.
See today’s analyst top recommended stocks >>
Currently, Endologix Inc has an average volume of 602.6K.
Based on 5 analyst ratings, the analyst consensus is Hold with an average price target of $4.55, reflecting a -44.2% downside. 11 different firms, including BMO Capital and BTIG, currently also have a Buy rating on the stock. One of the top 25 analysts, according to TipRanks.com, recently recommended Hold ELGX with a $4.75 price target.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Endologix, Inc. engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.
